XEN Gel Stent vs Trabeculectomy: Choosing the Right Glaucoma Surgery

The XEN Gel Stent is a tiny tube roughly the width of a human hair, made from a soft crosslinked gelatin material and measuring about 6 millimeters in length. During placement, an eye doctor inserts the stent through the white part of the eye to create a new channel for fluid drainage.

Once in place, aqueous humor (the clear fluid produced inside the eye) flows through the stent into the space beneath the conjunctiva (the clear outer covering of the eye), where surrounding tissue gradually absorbs it. The stent remains permanently in the eye. Surgeons often apply an antimetabolite medication during the procedure to reduce the risk of scarring that could block the new drainage pathway.

Trabeculectomy is a traditional filtering surgery with a long track record in glaucoma management. During the procedure, a small piece of tissue is removed from the wall of the eye, and a thin protective flap is created over the opening.

Fluid drains through this opening into a bleb, which is a small blister-like reservoir that forms just beneath the upper eyelid. Surrounding tissue absorbs the fluid over time, lowering pressure inside the eye. An antimetabolite medication is typically applied during surgery, and additional injections may be used afterward to help keep the drainage pathway open.

Despite their differences, XEN Gel Stent and trabeculectomy share the same fundamental goal and mechanism.

• Both create a new drainage channel through the eye wall to bypass the natural drainage system
• Both form a fluid collection area beneath the conjunctiva called a bleb
• Both rely on surrounding tissue to absorb the drained fluid and sustain lower pressure
• Both typically achieve greater pressure reduction than most patients obtain with eye drops alone

XEN and trabeculectomy are not the only surgical paths available. Depending on your glaucoma type, severity, and eye anatomy, other procedures may be a better fit.

• Tube shunt surgery, which drains fluid through a small implanted plate and tube, is often used when there is significant conjunctival scarring or after prior surgeries have failed
• Angle-based minimally invasive glaucoma surgery (MIGS), sometimes combined with cataract removal, may be appropriate for mild to moderate cases
• Cyclophotocoagulation, a laser procedure targeting the fluid-producing tissue of the eye, is considered for eyes not suited to incisional filtering surgery

Your eye doctor will explain when any of these alternatives may be safer or more effective than a bleb-forming procedure.

Most XEN stent patients notice meaningful improvement within one to two weeks. The eye may feel mildly scratchy or irritated for the first several days, and vision often remains somewhat blurry as healing progresses. By four to six weeks, many patients have reached their final pressure result and completed most of the healing process.

An in-office needling procedure, which involves gently breaking up scar tissue around the stent using a fine needle, is commonly needed in the first weeks if pressure begins to rise. This is a routine part of XEN management and does not mean the surgery has failed.

Trabeculectomy requires a longer, more closely monitored recovery. The first two weeks demand careful protection of the surgical site and strict attention to activity restrictions. Vision typically stabilizes over three to six weeks as the bleb forms and matures.

Final pressure results may take up to three months as the drainage pathway settles into a long-term equilibrium. Vision fluctuations during this time are common, particularly while sutures are being adjusted or removed to optimize drainage.

After either surgery, you will use antibiotic and anti-inflammatory eye drops for several weeks to prevent infection and control scarring. These medications are a critical part of recovery and should be used exactly as directed.

• Steroid drops reduce swelling and limit excessive scar tissue formation
• Antibiotic drops protect against infection during the healing period
• The drop schedule gradually tapers over weeks to months
• Trabeculectomy typically requires a longer steroid taper than XEN placement
• Your surgeon may perform in-office 5-fluorouracil (anti-scarring) injections after trabeculectomy to further support healing
• Steroid drops can raise eye pressure in some patients, so never adjust or stop your drops without your surgeon's guidance
• Some glaucoma drops may need to be restarted if additional pressure lowering is required

Avoid heavy lifting, straining, and bending at the waist for at least two weeks after either surgery, as these activities raise pressure inside the eye and can disrupt the healing surgical site. Keep water, soap, and cosmetics away from the eye for the period your surgeon specifies, and wear your protective eye shield at night to prevent accidental rubbing.

• Avoid swimming and hot tubs until your surgeon gives specific clearance
• Contact lens wear in the operated eye must wait until cleared by your surgeon, and some patients with a filtering bleb are not good candidates for contact lens use in that eye long term
• Strenuous exercise should be avoided for three to four weeks after either procedure
• Contact sports should wait until complete healing, typically around three months

We typically schedule visits the day after surgery, then at one week, two weeks, one month, and three months. These appointments allow us to monitor pressure, check for complications, and make medication adjustments as needed.

Trabeculectomy patients generally need more frequent early visits because suture adjustments or removal may be required to fine-tune drainage. XEN patients need close monitoring as well, with earlier visits scheduled if needling or bleb revision becomes necessary.

In many cases, yes. If XEN stent placement does not achieve sufficient pressure control, trabeculectomy can often still be performed in a different area of the eye. Going in the reverse direction is also possible but may be more complicated, since scarring from a prior trabeculectomy can limit where a stent can safely be placed. Each situation is assessed individually based on your eye anatomy and the extent of any scarring.

Many patients significantly reduce their drop burden or eliminate medications entirely after a successful procedure, but this is not guaranteed for everyone. Some patients still need one or two drops to reach their individualized target pressure. The realistic goal is better pressure control with less medication dependency, rather than a certain outcome of being drop-free. Your surgeon will give you an honest expectation based on your specific case.

Trabeculectomy creates a larger, more controllable drainage opening that can be fine-tuned after surgery through suture adjustment and laser suture lysis. This allows very precise titration of the drainage rate, which is why it consistently achieves lower final pressures than the XEN stent. When your optic nerve has very little reserve left, that extra degree of pressure reduction can be the difference between preserving useful vision and losing it.

Yes, and this is one of the most common reasons a tube shunt is recommended over either bleb-forming procedure. Extensive conjunctival scarring from prior surgeries, certain secondary glaucomas like neovascular or uveitic types, and previous failed filtering surgeries are all situations where a tube shunt may offer a more predictable outcome. Your eye doctor will evaluate your conjunctival health and surgical history to determine whether a tube shunt should be part of the conversation.

Pressure measurements taken at each follow-up visit are the primary way we track whether the procedure is achieving its goal. We also monitor bleb appearance and optic nerve stability over time. If pressure begins to rise during the early healing period, an in-office needling or suture adjustment may restore adequate flow before the situation becomes a concern. This is why closely attending all scheduled follow-up visits is essential to surgical success.

If pressure rises after initial success, there are several options depending on the cause. These include laser treatment directed at the surgical area, needling to disrupt scar tissue, reintroducing or adjusting glaucoma drops, or performing another procedure in a different location on the eye. The right approach depends on how much the pressure has risen, the current state of your optic nerve, and what surgeries have already been performed. Early detection through regular monitoring gives us the most options.